Literature DB >> 33752554

8-Mercaptoguanine-based inhibitors of Mycobacterium tuberculosis dihydroneopterin aldolase: synthesis, in vitro inhibition and docking studies.

Alexia de Matos Czeczot1,2, Candida Deves Roth1, Rodrigo Gay Ducati1,3, Kenia Pissinate1, Raoní Scheibler Rambo1, Luís Fernando Saraiva Macedo Timmers3, Bruno Lopes Abbadi1, Fernanda Souza Macchi1,2, Víctor Zajaczkowski Pestana1, Luiz Augusto Basso1,2,4, Pablo Machado1,2, Cristiano Valim Bizarro1,2.   

Abstract

The dihydroneopterin aldolase (DHNA, EC 4.1.2.25) activity of FolB protein is required for the conversion of 7,8-dihydroneopterin (DHNP) to 6-hydroxymethyl-7,8-dihydropterin (HP) and glycolaldehyde (GA) in the folate pathway. FolB protein from Mycobacterium tuberculosis (MtFolB) is essential for bacilli survival and represents an important molecular target for drug development. S8-functionalized 8-mercaptoguanine derivatives were synthesised and evaluated for inhibitory activity against MtFolB. The compounds showed IC50 values in the submicromolar range. The inhibition mode and inhibition constants were determined for compounds that exhibited the strongest inhibition. Additionally, molecular docking analyses were performed to suggest enzyme-inhibitor interactions and ligand conformations. To the best of our knowledge, this study describes the first class of MtFolB inhibitors.

Entities:  

Keywords:  8-mercaptoguanine; MtDHNA/MtFolB inhibition; Tuberculosis; dihydroneopterin aldolase

Mesh:

Substances:

Year:  2021        PMID: 33752554      PMCID: PMC7993393          DOI: 10.1080/14756366.2021.1900157

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  18 in total

Review 1.  The challenge of new drug discovery for tuberculosis.

Authors:  Anil Koul; Eric Arnoult; Nacer Lounis; Jerome Guillemont; Koen Andries
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

2.  Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.

Authors:  William J Sanders; Vicki L Nienaber; Claude G Lerner; J Owen McCall; Sean M Merrick; Susan J Swanson; John E Harlan; Vincent S Stoll; Geoffrey F Stamper; Stephen F Betz; Kevin R Condroski; Robert P Meadows; Jean M Severin; Karl A Walter; Peter Magdalinos; Clarissa G Jakob; Rolf Wagner; Bruce A Beutel
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.

Authors:  Behnoush Hajian; Eric Scocchera; Carolyn Shoen; Jolanta Krucinska; Kishore Viswanathan; Narendran G-Dayanandan; Heidi Erlandsen; Alexavier Estrada; Katarína Mikušová; Jana Korduláková; Michael Cynamon; Dennis Wright
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

Review 4.  Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.

Authors:  Marcio V Bertacine Dias; Jademilson C Santos; Gerardo A Libreros-Zúñiga; João A Ribeiro; Sair M Chavez-Pacheco
Journal:  Future Med Chem       Date:  2018-04-09       Impact factor: 3.808

5.  8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.

Authors:  Matthew L Dennis; Michael D Lee; Jitendra R Harjani; Mohamed Ahmed; Aaron J DeBono; Noel P Pitcher; Zhong-Chang Wang; Sandeep Chhabra; Nicholas Barlow; Raphaël Rahmani; Ben Cleary; Olan Dolezal; Meghan Hattarki; Luigi Aurelio; Jeremy Shonberg; Bim Graham; Thomas S Peat; Jonathan B Baell; James D Swarbrick
Journal:  Chemistry       Date:  2018-01-09       Impact factor: 5.236

6.  Regulation by oligomerization in a mycobacterial folate biosynthetic enzyme.

Authors:  Celia W Goulding; Marcin I Apostol; Michael R Sawaya; Martin Phillips; Angineh Parseghian; David Eisenberg
Journal:  J Mol Biol       Date:  2005-04-02       Impact factor: 5.469

7.  New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.

Authors:  Bruno Couto Giacobbo; Kenia Pissinate; Valnês Rodrigues-Junior; Anne Drumond Villela; Estêvão Silveira Grams; Bruno Lopes Abbadi; Fernanda Teixeira Subtil; Nathalia Sperotto; Rogério Valim Trindade; Davi Fernando Back; Maria Martha Campos; Luiz Augusto Basso; Pablo Machado; Diógenes Santiago Santos
Journal:  Eur J Med Chem       Date:  2016-11-23       Impact factor: 6.514

8.  One substrate, five products: reactions catalyzed by the dihydroneopterin aldolase from Mycobacterium tuberculosis.

Authors:  Clarissa M Czekster; John S Blanchard
Journal:  J Am Chem Soc       Date:  2012-11-26       Impact factor: 15.419

Review 9.  Tuberculosis.

Authors:  Madhukar Pai; Marcel A Behr; David Dowdy; Keertan Dheda; Maziar Divangahi; Catharina C Boehme; Ann Ginsberg; Soumya Swaminathan; Melvin Spigelman; Haileyesus Getahun; Dick Menzies; Mario Raviglione
Journal:  Nat Rev Dis Primers       Date:  2016-10-27       Impact factor: 52.329

10.  Structure of S. aureus HPPK and the discovery of a new substrate site inhibitor.

Authors:  Sandeep Chhabra; Olan Dolezal; Brett M Collins; Janet Newman; Jamie S Simpson; Ian G Macreadie; Ross Fernley; Thomas S Peat; James D Swarbrick
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.